Table 3.
Outcome | Predictor | Quality of Evidence | Summary of findings (narrative of effect size) | ||||
---|---|---|---|---|---|---|---|
RoB | Inconsistency | Indirectness | Imprecision | QoE summary | |||
Mechanical ventilation | Bulbar weakness | ↓ | ↓ | ↓ | Very low | OR ranging from 1.96 to 48.08 (of note, large 95% CI); in some studies, facial-bulbar not separated/cranial nerve dysfunction and bulbar weakness used interchangeably | |
Mechanical ventilation | Degree of motor weakness (limb strength less than antigravity, MRC grade) on admission or nadir | ↓ | ↓ | Low | OR ranging from 2.5 to 87 (of note, large 95% CI) depending on threshold for MRC sum score | ||
Mechanical ventilation | Rapid disease progression | ↓ | ↓ | ↓ | Very low | OR estimates not consistently performed; ranging from 1.68 to 25; different definition of rapid progression | |
Mechanical ventilation | Neck weakness | ↓ | ↓ | ↓ | ↓ | Very low | OR 4.34 to 9.86 (large 95% CI) |
Mechanical ventilation | Autonomic dysfunction | ↓↓ | ↓ | ↓ | Very low | Variable definition of autonomic dysfunction | |
Mechanical ventilation | EGRIS | ↓ | Moderate | AUC 0.82; in another validation cohort, AUC was 0.86 (0.80–0.93). Lowest AUC reported 0.63 | |||
Mechanical ventilation | Sharshar Score | ↓ | ↓ | Low |
AUC 0.81 (0.72–0.90) Only one validation study |
||
Mechanical ventilation | New normogram | ↓ | ↓ | Low |
AUC 0,85, C-index 0.86 (95% CI 0.77–0.94) Only one validation study |
||
Functional outcome | Need for mechanical ventilation | ↓ | ↓ | Low | OR 2.5–16 (for poor outcome) | ||
Functional outcome | Axonal electrophysiologic subtype | ↓ | ↓ | ↓ | Very low | OR 2–14.45 | |
Functional outcome | Age | ↓ | ↓ | Low | OR 1.3–10.3 (dependent on age categories or per year) | ||
Functional Outcome | Disability grade at nadir | ↓ | ↓ | Low | OR 2.9–8.88, variable scales used to assess both intake and outcome | ||
Independent ambulation | Disability grade at nadir (MRC sum score, GBSD score) | ↓ | ↓ | Low | OR to 3–4 for MRC sum score > 40 | ||
Independent ambulation | Age | ↓ | ↓ | Low | OR 1.08–3.8 (dependent on age categories or per year) | ||
Independent ambulation | Progression of weakness (speed) | ↓ | ↓ | ↓ | Very low | OR 3.8–8.6 (for poor outcome) | |
Independent ambulation | EGOS | ↓ | Moderate | AUC 0·85, 95% CI 0·81–0·89 | |||
Independent ambulation | mEGOS | ↓ | Moderate | after 1 week AUC 0.84–0.87 and at admission the AUC is 0.73–0.77. In another validation cohort, the AUC was 0.75 (0.70–0.80) after 1 week and 0.74 (0.69–0.79) at admission |
OR Odds ratio; CI Confidence interval; MRC Medical research council; EGRIS Erasmus Guillain Barré Syndrome Respiratory Insufficiency score; AUC Area under the curve; EGOS Erasmus Guillain Barré Syndrome Outcome Score; mEGOS modified Erasmus Guillain Barré Syndrome Outcome Score